Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph not_applicable

67%

Ph phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(2)

Detailed Status

Completed4

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (20.0%)

N/A4 (80.0%)

Trials by Status

completed467%

unknown233%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?

NCT00619970

unknownphase_1

Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex

NCT00956150

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT04705662Not Applicable

GI Effects of Iron in Healthy Volunteers

Completed

NCT04094558Not Applicable

Validation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule

Completed

NCT03141268

Rapid Orocecal Transit Time and Fermentation in IBS.

Unknown

NCT00619970Not Applicable

Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?

Completed

NCT00956150Phase 1

Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex

Unknown

NCT00956397Not Applicable

Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 6